Your browser is no longer supported. Please, upgrade your browser.
Settings
CSBR Champions Oncology, Inc. daily Stock Chart
CSBR [NASD]
Champions Oncology, Inc.
Index- P/E- EPS (ttm)-0.03 Insider Own20.87% Shs Outstand11.72M Perf Week-3.52%
Market Cap90.01M Forward P/E15.36 EPS next Y0.50 Insider Trans0.00% Shs Float9.33M Perf Month-8.35%
Income-0.30M PEG- EPS next Q0.03 Inst Own54.60% Short Float2.23% Perf Quarter-2.78%
Sales24.30M P/S3.70 EPS this Y79.20% Inst Trans-0.33% Short Ratio7.66 Perf Half Y-19.83%
Book/sh0.20 P/B38.40 EPS next Y100.00% ROA-2.70% Target Price15.50 Perf Year-7.02%
Cash/sh0.28 P/C27.28 EPS next 5Y15.00% ROE-20.50% 52W Range6.86 - 17.90 Perf YTD-1.66%
Dividend- P/FCF128.59 EPS past 5Y37.90% ROI- 52W High-58.10% Beta1.05
Dividend %- Quick Ratio1.00 Sales past 5Y19.50% Gross Margin47.30% 52W Low9.33% ATR0.46
Employees92 Current Ratio1.00 Sales Q/Q25.50% Oper. Margin-1.20% RSI (14)42.42 Volatility9.21% 5.18%
OptionableNo Debt/Eq0.09 EPS Q/Q-364.00% Profit Margin-1.00% Rel Volume0.20 Prev Close7.68
ShortableYes LT Debt/Eq0.00 EarningsJul 15 AMC Payout- Avg Volume27.20K Price7.50
Recom1.50 SMA20-5.90% SMA50-12.46% SMA200-24.27% Volume2,668 Change-2.34%
Jul-15-19 04:35PM  Champions Oncology Reports Record Quarterly Revenue of $7.7 Million For The Fourth Quarter Ended April 30, 2019 ACCESSWIRE +12.94%
Jul-12-19 10:00AM  Champions Oncology to Announce Fourth Quarter Financial Results on Monday, July 15, 2019 ACCESSWIRE
Jul-02-19 09:35AM  Calculating The Intrinsic Value Of Champions Oncology, Inc. (NASDAQ:CSBR) Simply Wall St.
May-31-19 09:37AM  How Many Champions Oncology, Inc. (NASDAQ:CSBR) Shares Have Insiders Sold, In The Last Year? Simply Wall St.
May-30-19 08:30AM  Champions Oncology Partners with TransCure bioServices to Expand European Business and Operations ACCESSWIRE
May-01-19 08:07AM  What Kind Of Shareholder Owns Most Champions Oncology, Inc. (NASDAQ:CSBR) Stock? Simply Wall St. -5.07%
Apr-17-19 09:49AM  Moving Average Crossover Alert: Champions Oncology Zacks -8.08%
Apr-16-19 10:51AM  New Strong Sell Stocks for April 16th Zacks
Apr-01-19 08:54AM  New Strong Sell Stocks for April 1st Zacks -7.35%
Mar-27-19 10:03AM  New Strong Sell Stocks for March 27th Zacks
Mar-25-19 10:42AM  New Strong Sell Stocks for March 25th Zacks
Mar-18-19 04:00PM  Champions Oncology Reports Quarterly Revenue of $6.4 Million ACCESSWIRE
Mar-06-19 08:30AM  Champions Oncology to Announce Third Quarter Financial Results on Monday, March 18, 2019 ACCESSWIRE
Mar-04-19 11:40PM  Champions Oncology (CSBR) Q3 Earnings: What's in Store? Zacks -6.39%
Jan-10-19 08:43AM  Weakness Seen in Champions Oncology (CSBR) Estimates: Should You Stay Away? Zacks
Dec-17-18 03:30PM  Champions Oncology Participates in Pre-Clinical Studies to Identify Novel Therapy for Childhood Cancer ACCESSWIRE
03:00PM  Champions Oncology Reports Quarterly Revenue of $6.7 Million ACCESSWIRE
Dec-10-18 04:30PM  Champions Oncology to Announce Second Quarter Financial Results on Monday, December 17, 2018 PR Newswire
Nov-22-18 05:45PM  Champions Oncology (CSBR) Outpaces Stock Market Gains: What You Should Know Zacks
Nov-16-18 05:45PM  Champions Oncology (CSBR) Stock Sinks As Market Gains: What You Should Know Zacks
Nov-15-18 07:20AM  Analysis: Positioning to Benefit within Red Lion Hotels, P.A.M. Transportation Services, Champions Oncology, Kingstone Companies, Applied DNA Sciences, and Innodata Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Nov-07-18 08:30AM  Champions Oncology to Participate in the 9th Annual Craig-Hallum Alpha Select Conference PR Newswire +7.24%
Nov-05-18 05:45PM  Champions Oncology (CSBR) Outpaces Stock Market Gains: What You Should Know Zacks
Nov-02-18 07:27AM  Champions Oncology Sees Hammer Chart Pattern: Time to Buy? Zacks
Oct-29-18 09:30AM  Has Champions Oncology (CSBR) Outpaced Other Medical Stocks This Year? Zacks -17.93%
Oct-23-18 05:45PM  Champions Oncology (CSBR) Gains As Market Dips: What You Should Know Zacks
Oct-12-18 09:30AM  Has Champions Oncology (CSBR) Outpaced Other Medical Stocks This Year? Zacks
Oct-04-18 06:55AM  Bull Of The Day: Champions Oncology (CSBR) Zacks +10.65%
Oct-01-18 12:10PM  Best ETFs & Stocks From the Top Sector of Q3 Zacks -17.57%
Sep-28-18 09:15AM  Tech Breaks S&P Out of Slump Zacks
Sep-21-18 10:00AM  Looking for a Top Momentum Pick? Why Champions Oncology (CSBR) is a Great Choice Zacks
Sep-20-18 09:15AM  S&P, Dow Nearing All-Time Highs Zacks -5.51%
Sep-13-18 04:05PM  Champions Oncology Reports Record Quarterly Revenue of $6.2 Million PR Newswire
08:30AM  Champions Oncology to Participate at the Janney Montgomery Scott Healthcare Conference 2018 in New York PR Newswire
Sep-06-18 10:59AM  Champions Oncology (CSBR) Q1 Earnings Preview: How Are Events Shaping Up? Zacks
Aug-28-18 08:30AM  Champions Oncology to Announce First Quarter Financial Results on Thursday, September 13, 2018 PR Newswire
Aug-08-18 08:30AM  Champions Oncology Granted Full Accreditation by the AAALAC PR Newswire
Jul-26-18 04:02PM  Champions Oncology Reports Record Annual Revenue Exceeding $20M for Fiscal Year Ended April 30, 2018 PR Newswire
Jul-12-18 08:30AM  Champions Oncology to Announce Fourth Quarter Financial Results on Thursday, July 26, 2018 PR Newswire
Jun-18-18 08:30AM  Champions Oncology Partners with Puma Biotechnology and NSABP Foundation on Metastatic Breast and Colon Cancer Co-clinical PDX Studies PR Newswire +5.88%
May-03-18 08:30AM  Champions Oncology to Present at the 3rd annual Disruptive Growth & Healthcare Conference on May 9th PR Newswire
May-01-18 08:30AM  Champions Oncology Adds Amy Wesa, Ph.D, as Director of Immuno-Oncology Research PR Newswire
Apr-04-18 08:30AM  Champions Oncology to Present at The MicroCap Conference on April 10th in New York City at the Essex House PR Newswire
Mar-28-18 07:10AM  Blog Exposure - Lexicon Announced NDA and MAA Submissions for Sotagliflozin to Treat Adults with Type-1 Diabetes ACCESSWIRE
Mar-15-18 04:01PM  Champions Oncology Reports Quarterly Revenue of $5.1 Million PR Newswire +7.10%
12:45PM  Champions Oncology, Inc. to Host Earnings Call ACCESSWIRE
08:46AM  Does Champions Oncology Incs (NASDAQ:CSBR) Past Performance Indicate A Stronger Future? Simply Wall St.
Mar-07-18 08:30AM  Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 15, 2018 PR Newswire
Feb-27-18 07:19PM  How Financially Strong Is Champions Oncology Inc (NASDAQ:CSBR)? Simply Wall St.
Feb-26-18 08:30AM  Champions Oncology to Participate at the 30th Annual ROTH Conference PR Newswire
Feb-21-18 08:30AM  Motivated Patients with ROS1 Cancer Initiate Global Research Study PR Newswire
Feb-14-18 06:29PM  February Insights Into Healthcare Stocks: Champions Oncology Inc (NASDAQ:CSBR) Simply Wall St. +6.05%
Dec-29-17 05:45PM  Why Champions Oncology Incs (NASDAQ:CSBR) CEO Pay Matters To You Simply Wall St.
Dec-19-17 09:16AM  Champions Oncology, Inc. :CSBR-US: Earnings Analysis: Q2, 2018 By the Numbers : December 19, 2017 Capital Cube
Dec-18-17 07:40AM  Blog Exposure - FDA Granted Tentative Approval for Expanded Label for Egalets ARYMO ER Extended-Release Tablets C-II ACCESSWIRE
Dec-07-17 04:15PM  Champions Oncology Reports Record Quarterly Revenue of $5.2 Million PR Newswire +7.06%
06:23AM  Was Champions Oncology Incs (CSBR) Earnings Growth Better Than Industry? Simply Wall St.
Nov-28-17 08:05AM  Champions Oncology to Announce Second Quarter Financial Results on Thursday, December 7, 2017 PR Newswire
Nov-27-17 04:01PM  Champions Oncology to Present at 10th Annual Main Event on December 5 ACCESSWIRE
05:50AM  Champions Oncology Inc (CSBR): Time For A Financial Health Check Simply Wall St.
Nov-07-17 08:00AM  Champions Oncology to Participate in the Craig-Hallum Alpha Select Investor Conference PR Newswire
Oct-12-17 12:34PM  Champions Oncology Inc (CSBR) And The Healthcare Industry Prospect For 2017 Simply Wall St.
Sep-26-17 08:30AM  Champions Oncology announces $2 million award from the National Cancer Institute (NCI) to develop and evaluate prostate cancer PDX models PR Newswire
Sep-18-17 02:14PM  Champions Oncology, Inc. :CSBR-US: Earnings Analysis: Q1, 2018 By the Numbers : September 18, 2017 Capital Cube +5.28%
09:15AM  Champions Oncology announces publication highlighting clinical correlation between patient-derived xenograft (PDX) model responses and patient responses to oncology therapies PR Newswire
Sep-14-17 04:30PM  Champions Oncology Reports Record Quarterly Revenue of $5 Million PR Newswire -5.29%
Sep-07-17 05:00PM  Champions Oncology to Announce First Quarter Financial Results on Thursday, September 14, 2017 PR Newswire
Aug-21-17 08:30AM  Champions Oncology Announces Strategic Collaboration with AstraZeneca to Develop Unique Cohorts of Patient-Derived Xenograft (PDX) Models PR Newswire +6.27%
Aug-18-17 08:30AM  Champions Oncology Announces Research Collaboration with The Addario Lung Cancer Medical Institute to Develop Unique Cohort of Patient-Derived Xenograft (PDX) Models PR Newswire
Aug-15-17 04:57AM  The Addario Lung Cancer Medical Institute, Champions Oncology and Motivated Patients Announce a Research Collaboration and Launch of a Patient Driven Clinical Study in ROS1 Positive Cancer PR Newswire
Aug-04-17 07:20AM  Corporate News Blog - Theravance Biopharmas Velusetrag Successful in Mid-Stage Gastroparesis Study ACCESSWIRE
Aug-01-17 10:07AM  Champions Oncology, Inc. :CSBR-US: Earnings Analysis: Q4, 2017 By the Numbers : August 1, 2017 Capital Cube +10.92%
Jul-27-17 04:01PM  Champions Oncology Reports 38% Revenue Growth for Fiscal Year Ended April 30, 2017 PR Newswire
Jul-17-17 08:30AM  Champions Oncology Schedules Fourth Quarter and Fiscal Year 2017 Earnings Call PR Newswire
Mar-23-17 01:04PM  CHAMPIONS ONCOLOGY, INC. Financials
Mar-22-17 10:10AM  Champions Oncology, Inc. :CSBR-US: Earnings Analysis: Q3, 2017 By the Numbers : March 22, 2017 Capital Cube
10:10AM  Champions Oncology, Inc. :CSBR-US: Earnings Analysis: Q3, 2017 By the Numbers : March 22, 2017
Mar-17-17 01:56PM  CHAMPIONS ONCOLOGY, INC. Files SEC form 10-Q, Quarterly Report
Mar-16-17 04:03PM  CHAMPIONS ONCOLOGY, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
04:01PM  Champions Oncology Reports 40% Revenue Growth PR Newswire
09:00AM  Champions Oncology Announces Plan to Open New Lab Facility in Rockville, Maryland PR Newswire
07:07AM  Q3 2017 Champions Oncology Inc Earnings Release - After Market Close
Mar-07-17 08:00AM  Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 16, 2017 PR Newswire
Feb-16-17 09:36AM  Champions Oncology Announces New Collection of Patient-Derived Xenograft (PDX) Models Available for Translational Research PR Newswire
Jan-26-17 01:29PM  CHAMPIONS ONCOLOGY, INC. Files SEC form 8-K, Change in Directors or Principal Officers
Jan-19-17 10:38AM  Champions Oncology Retains Hayden IR to Execute Comprehensive Investor Relations Program PR Newswire
Dec-16-16 08:34AM  Champions Oncology, Inc. :CSBR-US: Earnings Analysis: Q2, 2017 By the Numbers : December 16, 2016 Capital Cube
08:34AM  Champions Oncology, Inc. :CSBR-US: Earnings Analysis: Q2, 2017 By the Numbers : December 16, 2016
Dec-14-16 04:08PM  CHAMPIONS ONCOLOGY, INC. Files SEC form 10-Q, Quarterly Report
06:53AM  How Champions Oncology Inc (CSBR) Stacks Up Against Its Peers Insider Monkey
06:53AM  How Champions Oncology Inc (CSBR) Stacks Up Against Its Peers at Insider Monkey
Nov-29-16 04:16PM  CHAMPIONS ONCOLOGY, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors or Pr
04:15PM  Champions Oncology Reports 50% Revenue Growth, Accelerated Progress on Path to Profitability and Future Role Changes of the Senior Leadership PR Newswire
07:07AM  Q2 2017 Champions Oncology Inc Earnings Release - After Market Close
Nov-23-16 10:20AM  Champions Oncology to Announce Second Quarter Financial Results on Tuesday, November 29, 2016 PR Newswire
Nov-17-16 04:05PM  Champions Oncology Signs $2 million Contract PR Newswire
Nov-16-16 07:05PM  Champions Oncology Inc (CSBR) Stock: Have We Met? at Insider Monkey
Nov-15-16 02:27PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Delaware Law by Certain Officers and Directors of Champions Oncology, Inc. Business Wire
Nov-01-16 12:06PM  CHAMPIONS ONCOLOGY, INC. Files SEC form 8-K, Change in Directors or Principal Officers
Oct-25-16 08:59AM  Insider Selling at Dominos Pizza Inc. (DPZ) and Intel Corporation (INTC), Plus Insider Buying at Three Other Companies at Insider Monkey
Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Technology Platform, provides Personalized Oncology Solutions (POS) that assist physicians in developing personalized treatment options for cancer patients through tumor specific data obtained from drug panels and related personalized oncology services. The company also offers POS products, including personalized tumor boards that are designed to provide access to oncologists with expertise in particular tumor types; and provides access to gene sequencing that analyzes the genetic makeup of patient's tumor for the purpose of identifying potentially useful drugs. In addition, it offers Translational Oncology Solutions, including a preclinical Tumorgraft platform to pharmaceutical and biotechnology companies. The company markets its products through Internet, word of mouth, and sales force to patients and physicians. Champions Oncology, Inc. has collaboration partnerships with NSABP Foundation, Inc. and Puma Biotechnology, Inc. to develop patient derived xenograft models in two multi-center co-clinical patient derived xenograft trials. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Morris RonnieCEOJan 16Option Exercise4.804,16720,002837,168Jan 16 03:39 PM
ACKERMAN JOELDirectorJan 02Option Exercise4.804,16720,0021,113,877Jan 04 03:01 PM
Morris RonnieCEODec 19Buy7.4420,000148,800833,001Dec 20 03:18 PM
Mendelson Daniel NewmanDirectorNov 06Sale13.755,00068,75057,500Nov 08 05:02 PM
ACKERMAN JOELDirectorOct 12Option Exercise2.10100,000210,0001,121,731Oct 12 02:45 PM
ACKERMAN JOELDirectorOct 01Sale17.0222,535383,5461,021,731Oct 03 10:22 AM
Mendelson Daniel NewmanDirectorSep 20Sale13.028,333108,49662,500Oct 05 10:30 AM